Hovione Expands Particle Design Solutions
Hovione Expands Particle Design Solutions to Solve Bioavailability and Other Drug Delivery Challenges
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione Expands Particle Design Solutions to Solve Bioavailability and Other Drug Delivery Challenges
Hovione Announces the Appointment of Conrad Winters, PhD as Drug Product Development Director
Drug Development and Delivery, October 2012
The 12th successful inspection in 18 months
European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA)
Hovione’s TwinCaps® inhaler in Phase III clinical trials for influenza
Pharmaceutical Technology Sourcing and Management, July 2006
Pharmaceutical Technology Europe, February 2014
Drug Delivery Technology, April 2007